Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Disease Progression and CHEK2[original query] |
---|
Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression. Oncotarget 2016 Mar . Lasorsa Vito Alessandro, Formicola Daniela, Pignataro Piero, Cimmino Flora, Calabrese Francesco Maria, Mora Jaume, Esposito Maria Rosaria, Pantile Marcella, Zanon Carlo, De Mariano Marilena, Longo Luca, Hogarty Michael D, de Torres Carmen, Tonini Gian Paolo, Iolascon Achille, Capasso Mar |
Distinct Mutation Patterns Reveal Melanoma Subtypes and Influence Immunotherapy Response in Advanced Melanoma Patients. Cancers 2020 8 12 (9): . Hilke Franz J, Sinnberg Tobias, Gschwind Axel, Niessner Heike, Demidov German, Amaral Teresa, Ossowski Stephan, Bonzheim Irina, Röcken Martin, Riess Olaf, Garbe Claus, Schroeder Christopher, Forschner Andr |
Efficacy of olaparib in advanced cancers with germline or somatic mutations in BRCA1, BRCA2, CHEK2 and ATM, a Belgian Precision tumor-agnostic phase II study. ESMO open 2023 10 8 (6): 102041. S Joris, H Denys, J Collignon, M Rasschaert, D T'Kint de Roodenbeke, F P Duhoux, J-L Canon, S Tejpar, J Mebis, L Decoster, P Aftimos, J De Grè |
- Page last reviewed:Feb 1, 2024
- Content source: